Skip to main content
Market intelligence
AGIOHealthcare

Agios Pharmaceuticals Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 4, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 4, 2026Sarah GheuensChief Medical OfficerSale30,000$30.48$914,400
Jul 1, 2026Sarah GheuensChief Medical OfficerSale4,007$37.56$150,503